Relypsa
Latest round
- Series C
Last raised
- Oct 2012
Total raised
- $166M
Investors
- 8
About Relypsa
Established in 2007, Relypsa is a US based biopharmaceutical company mainly focused on the discovery and development of non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases.
Who invested in Relypsa
8 investors across 6 rounds
See all investors in Relypsa
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Relypsa
Who invested in Relypsa?
Relypsa has 8 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Relypsa raised?
Relypsa has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did Relypsa last raise money?
Relypsa's most recent round on record is a Series C, in Oct 2012.
What does Relypsa do?
Established in 2007, Relypsa is a US based biopharmaceutical company mainly focused on the discovery and development of non-absorbed polymeric drugs for important applications in cardiovascular and renal diseases.
Where is Relypsa headquartered?
Relypsa is headquartered in Redwood City, US.
Which VCs invest in companies like Relypsa?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Relypsa's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Relypsa? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.